Cita APA

Baumann, A., Burger, K., Brandt, A., Staltner, R., Jung, F., Rajcic, D., . . . Bergheim, I. (2022). GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease. Web

Citación estilo Chicago

Baumann, Anja, Katharina Burger, Annette Brandt, Raphaela Staltner, Finn Jung, Dragana Rajcic, Maria Jose Lorenzo Pisarello, and Ina Bergheim. GW9662, a Peroxisome Proliferator-activated Receptor Gamma Antagonist, Attenuates the Development of Non-alcoholic Fatty Liver Disease. 2022.

Cita MLA

Baumann, Anja, et al. GW9662, a Peroxisome Proliferator-activated Receptor Gamma Antagonist, Attenuates the Development of Non-alcoholic Fatty Liver Disease. 2022.